Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00560573. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Pemetrexed, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT00310050. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy
ClinicalTrials.gov study NCT01938716. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer
ClinicalTrials.gov study NCT03579771. IPD Sharing: NO. Countries: 1. Publications: 0.
Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00623233. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC
ClinicalTrials.gov study NCT00283244. IPD Sharing: NO. Countries: 1. Publications: 0.
Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT01080248. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00618826. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT01431794. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer
ClinicalTrials.gov study NCT02139358. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer
ClinicalTrials.gov study NCT02560038. IPD Sharing: NO. Countries: 1. Publications: 0.
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT00101283. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nab-Paclitaxel Combined With Gemcitabine Adjuvant Chemotherapy After Radical Resection of Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT04077983. IPD Sharing: NO. Countries: 0. Publications: 3.
Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder Cancer
ClinicalTrials.gov study NCT01126749. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
ClinicalTrials.gov study NCT04577014. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and Survival
ClinicalTrials.gov study NCT00461708. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies
ClinicalTrials.gov study NCT00072514. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High
ClinicalTrials.gov study NCT02715804. IPD Sharing: Not stated. Countries: 22. Publications: 0.
Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT00847015. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT03086369. IPD Sharing: YES. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.